SpringWorks Therapeutics (SWTX)
(Delayed Data from NSDQ)
$39.14 USD
+0.30 (0.77%)
Updated Jun 13, 2024 04:00 PM ET
After-Market: $39.09 -0.05 (-0.13%) 7:00 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/7/24 |
---|---|
Current Quarter | -1.11 |
EPS Last Quarter | -1.18 |
Last EPS Surprise | -0.85% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -4.60 |
Next Year | -3.29 |
EPS (TTM) | -5.14 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 34.93M | 44.22M | 154.90M | 354.25M |
# of Estimates | 5 | 5 | 5 | 4 |
High Estimate | 38.51M | 49.99M | 173.89M | 377.16M |
Low Estimate | 31.40M | 38.00M | 135.23M | 311.48M |
Year ago Sales | 0.00M | 0.00M | 5.45M | 154.90M |
Year over Year Growth Est. | NA | NA | 2,743.69% | 128.70% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.11 | -1.02 | -4.60 | -3.29 |
# of Estimates | 5 | 5 | 6 | 5 |
Most Recent Consensus | -0.99 | -0.89 | -3.86 | -3.55 |
High Estimate | -0.99 | -0.89 | -3.86 | -1.88 |
Low Estimate | -1.32 | -1.13 | -6.33 | -4.93 |
Year ago EPS | -1.25 | -1.27 | -5.15 | -4.60 |
Year over Year Growth Est. | 11.20% | 19.69% | 10.68% | 28.45% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 4 | 4 | 3 | 3 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 1 | 1 | 3 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.11 | -1.02 | -4.60 | -3.29 |
7 Days Ago | -1.11 | -1.02 | -4.60 | -3.29 |
30 Days Ago | -1.11 | -1.02 | -4.60 | -3.29 |
60 Days Ago | -1.17 | -1.08 | -4.71 | -3.27 |
90 Days Ago | -1.17 | -1.08 | -4.71 | -3.27 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.11 | -1.02 | -4.60 | -3.29 |
Zacks Consensus Estimate | -1.11 | -1.02 | -4.60 | -3.29 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.18 | -1.44 | -1.27 | -1.25 | NA |
Estimate | -1.17 | -1.25 | -1.31 | -1.25 | NA |
Difference | -0.01 | -0.19 | 0.04 | 0.00 | -0.04 |
Surprise | -0.85% | -15.20% | 3.05% | 0.00% | -3.25% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more